Wolverine Asset Management’s PAVmed Inc. Series Z Warrant PAVMZ Stock Holding History

Wolverine Asset Management’s Portfolio PAVMZ Stock Details PAVMZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-40,757	Closed	-$6.11K	–	1945
2023 Q1	$6.11K	Sell	40,757 -13,977	-26%	-$2.76K	﹤0.01%	1518
2022 Q4	$12K	Sell	54,734 -48,193	-47%	-$20K	﹤0.01%	1599
2022 Q3	$45K	Sell	102,927 -3,023	-3%	-$2.06K	﹤0.01%	1625
2022 Q2	$52K	Sell	105,950 -10,647	-9%	-$6.7K	﹤0.01%	1554
2022 Q1	$95K	Sell	116,597 -43,249	-27%	-$44.5K	﹤0.01%	1318
2021 Q4	$255K	Sell	159,846 -36,484	-19%	-$128K	﹤0.01%	1176
2021 Q3	$1.36M	Buy	196,330 +35,424	+22%	+$191K	0.01%	624
2021 Q2	$780K	Sell	160,906 -8,248	-5%	-$30.6K	0.01%	744
2021 Q1	$478K	Buy	169,154 +155,673	+1,155%	+$314K	﹤0.01%	927
2020 Q4	$15K	Sell	13,481 -1,158	-8%	-$1.05K	﹤0.01%	1465
2020 Q3	$12K	Buy	14,639 +7,116	+95%	+$6.77K	﹤0.01%	1450
2020 Q2	$7K	Buy	+7,523	New	+$8.3K	﹤0.01%	1444

Other funds holding PAVMZ

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wolverine Asset Management's PAVMZ Position: Q2 2023 in Review

Wolverine Asset Management sold out of PAVmed Inc. Series Z Warrant (PAVMZ) in Q2 2023, closing a stake of 40,757 shares — an estimated $6.11K sold.

Wolverine Asset Management first reported a position in PAVMZ in Q2 2020 and held it in 12 quarters. The position peaked at $1.36M in Q3 2021. 6 funds tracked by Wall St. Rank hold PAVMZ as of Q2 2023.

Wolverine Asset Management reported no remaining PAVmed Inc. Series Z Warrant position as of Q2 2023 after selling out during the quarter.
Wolverine Asset Management sold 40,757 PAVmed Inc. Series Z Warrant shares in Q2 2023, an estimated $6.11K.
Wolverine Asset Management first reported a position in PAVmed Inc. Series Z Warrant in Q2 2020 and held it in 12 quarters.
Wolverine Asset Management's PAVmed Inc. Series Z Warrant position peaked at $1.36M in Q3 2021.
6 funds tracked by Wall St. Rank held PAVmed Inc. Series Z Warrant as of Q2 2023.

Based on Wolverine Asset Management's 13F filing for Q2 2023, filed 7 Aug 2023.